Cargando…

Podocalyxin is a marker of poor prognosis in colorectal cancer

BACKGROUND: Over two decades ago, a proposal was that two different colorectal cancer (CRC) entities existed, based on tumour location either proximal (right) or distal (left) of the splenic flexure. Proximal and distal tumours exhibit different clinical, epidemiological, and biological characterist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaprio, Tuomas, Fermér, Christian, Hagström, Jaana, Mustonen, Harri, Böckelman, Camilla, Nilsson, Olle, Haglund, Caj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226963/ https://www.ncbi.nlm.nih.gov/pubmed/25004863 http://dx.doi.org/10.1186/1471-2407-14-493

Ejemplares similares

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015)

A comparative study of two PODXL antibodies in 840 colorectal cancer patients
por: Kaprio, Tuomas, et al.
Publicado: (2014)

REG4 Independently Predicts Better Prognosis in Non-Mucinous Colorectal Cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2021)

High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients
por: Beilmann-Lehtonen, Ines, et al.
Publicado: (2023)

The Prognostic Importance of CD20(+) B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets
por: Edin, Sofia, et al.
Publicado: (2019)

Association between local immune cell infiltration, mismatch repair status and systemic inflammatory response in colorectal cancer
por: Gunnarsson, Ulf, et al.
Publicado: (2020)

Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2019)

The prognostic role of tissue TLR2 and TLR4 in colorectal cancer
por: Beilmann-Lehtonen, Ines, et al.
Publicado: (2020)

The possible dual role of Ang-2 in the prognosis of pancreatic cancer
por: Roos-Mattila, Matilda, et al.
Publicado: (2023)

Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer
por: Böckelman, Camilla, et al.
Publicado: (2018)

Prognostic Values of Tissue and Serum Angiogenic Growth Factors Depend on the Phenotypic Subtypes of Colorectal Cancer
por: Kasurinen, Jussi Herman, et al.
Publicado: (2023)

High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases
por: Peltonen, Reetta, et al.
Publicado: (2020)

Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis
por: Arpalahti, Leena, et al.
Publicado: (2018)

A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel
por: Björkman, Kajsa, et al.
Publicado: (2021)

Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer
por: Kaprio, Tuomas, et al.
Publicado: (2021)

Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer
por: Lanki, Mira, et al.
Publicado: (2019)

Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
por: Heby, Margareta, et al.
Publicado: (2020)

Lack of MMP-9 expression is a marker for poor prognosis in Dukes’ B colorectal cancer
por: Koskensalo, Selja, et al.
Publicado: (2012)

Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma
por: Kaasinen, Mirjami, et al.
Publicado: (2022)

N-glycomic profiling of colorectal cancer according to tumor stage and location
por: Holm, Matilda, et al.
Publicado: (2020)

N-glycomic Profiling as a Tool to Separate Rectal Adenomas from Carcinomas
por: Kaprio, Tuomas, et al.
Publicado: (2015)

The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy
por: Nurmi, Anna Maria, et al.
Publicado: (2022)

N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm
por: Nieminen, Heini, et al.
Publicado: (2023)

Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome
por: Kasurinen, Aaro, et al.
Publicado: (2019)

High PROX1 expression in gastric cancer predicts better survival
por: Laitinen, Alli, et al.
Publicado: (2017)

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2016)

L1TD1 - a prognostic marker for colon cancer
por: Chakroborty, Deepankar, et al.
Publicado: (2019)

Concomitant Tumor Expression of EGFR and TATI/SPINK1 Associates with Better Prognosis in Colorectal Cancer
por: Koskensalo, Selja, et al.
Publicado: (2013)

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
por: Larsson, A, et al.
Publicado: (2011)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Stage I–IV Colorectal Cancer Prognosis Can Be Predicted by Type and Number of Intratumoral Macrophages and CLEVER-1(+) Vessel Density
por: Ålgars, Annika, et al.
Publicado: (2021)

Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status
por: Sjöblom, Anni, et al.
Publicado: (2021)

Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth
por: Lemmetyinen, Toni T., et al.
Publicado: (2023)

Combined epithelial marker analysis of tumour budding in stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2018)

High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1
por: Kasurinen, Aaro, et al.
Publicado: (2019)

High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer
por: Carpén, Timo, et al.
Publicado: (2019)

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Salmiheimo, Aino, et al.
Publicado: (2016)

aMMP-8 POCT for Periodontal Disease: An Indicator of Poor Oral Health
por: Gupta, Shipra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_51efi7jqlt336g9prpsj6e9bmb